Karyopharm Therapeutics (KPTI) Insider Trading & Ownership $0.81 -0.02 (-2.78%) (As of 11/15/2024 08:54 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$1.46 M Get KPTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KPTI Insider Buying and Selling by Quarter Ad Banyan Hill PublishingTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a half years… Make no mistake, this division will definitely change YOUR financial future, for better or worse… That is why I’m sharing my post-election analysis of how this hidden division will impact your financial future…And how Trump’s victory has just kicked-opened the door to a “Financial Miracle” for every American. Karyopharm Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/4/2024Richard A PaulsonCEOSell3,607$0.88$3,174.16 8/6/2024Richard A PaulsonCEOSell3,608$0.93$3,355.44 7/30/2024Stuart PoultonEVPSell2,883$1.06$3,055.98 7/5/2024Richard A PaulsonCEOSell3,616$0.85$3,073.60 6/7/2024Deepika PakianathanDirectorSell231,548$0.95$219,970.60 6/5/2024Deepika PakianathanDirectorSell468,044$0.96$449,322.24 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/4/2024Michael MasonCFOSell652$0.99$645.48 6/4/2024Richard A PaulsonCEOSell3,592$0.99$3,556.08 6/3/2024Deepika PakianathanDirectorSell360,744$1.00$360,744.00 5/31/2024Deepika PakianathanDirectorSell204,394$0.95$194,174.30 5/6/2024Richard A PaulsonCEOSell3,576$1.13$4,040.88 4/22/2024Reshma RangwalaEVPSell6,789$1.17$7,943.13 4/4/2024Richard A PaulsonCEOSell3,563$1.29$4,596.27 3/5/2024Richard A PaulsonCEOSell3,573$1.30$4,644.90 2/29/2024Michael ManoSVPSell16,973$1.17$19,858.41 2/29/2024Michael MasonCFOSell27,687$1.17$32,393.79 2/29/2024Reshma RangwalaEVPSell15,667$1.17$18,330.39 2/29/2024Richard A PaulsonCEOSell80,470$1.17$94,149.90 2/27/2024Michael MasonCFOSell2,545$1.32$3,359.40 2/15/2024Stuart PoultonEVPSell5,847$1.33$7,776.51 2/6/2024Michael MasonCFOSell4,205$1.59$6,685.95 2/6/2024Richard A PaulsonCEOSell4,012$1.59$6,379.08 1/4/2024Richard A PaulsonCEOSell4,114$0.82$3,373.48 12/4/2023Richard A PaulsonCEOSell3,622$0.79$2,861.38 (Data available from 1/1/2013 forward) KPTI Insider Trading Activity - Frequently Asked Questions Who is on Karyopharm Therapeutics's Insider Roster? The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Jatin Shah, Michael Kauffman, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sharon Shacham, Sohanya Roshan Cheng, Stephen Mitchener, and Stuart Poulton. Learn more on insiders at KPTI. What percentage of Karyopharm Therapeutics stock is owned by insiders? 4.30% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings. Which Karyopharm Therapeutics insiders have been buying company stock? The following insider purchased KPTI shares in the last 24 months: Garen G Bohlin ($50,190.80). How much insider buying is happening at Karyopharm Therapeutics? Insiders have purchased a total of 41,140 KPTI shares in the last 24 months for a total of $50,190.80 bought. Which Karyopharm Therapeutics insiders have been selling company stock? The following insiders have sold KPTI shares in the last 24 months: Deepika Pakianathan ($1,224,211.14), Michael Mano ($25,029.45), Michael Mason ($86,230.06), Reshma Rangwala ($53,692.02), Richard A Paulson ($322,234.95), Sohanya Roshan Cheng ($48,237.77), Stephen Mitchener ($19,261.71), and Stuart Poulton ($34,391.10). How much insider selling is happening at Karyopharm Therapeutics? Insiders have sold a total of 1,595,379 Karyopharm Therapeutics shares in the last 24 months for a total of $1,813,288.20 sold. Karyopharm Therapeutics Key ExecutivesMr. Richard A. Paulson M.B.A. (Age 57)President, CEO & Director Compensation: $1.43M4 recent tradesMs. Sohanya Cheng M.B.A. (Age 41)Executive VP & Chief Commercial Officer Compensation: $742.95kMr. Stuart PoultonExecutive VP & Chief Development Officer1 recent tradesDr. Reshma Rangwala M.D. (Age 46)Ph.D., Executive VP, Chief Medical Officer & Head of Research Compensation: $777.32kDr. Mansoor Raza Mirza M.D. (Age 63)Clinical Consultant, Member of Scientific Advisory Board & Independent Director Compensation: $150kDr. Sharon Shacham M.B.A. (Age 54)Ph.D., Co-Founder & Chairman of Scientific Advisory Board Compensation: $1.4MMr. Cameron Peters (Age 64)Vice President of Finance, Assistant Treasurer & Principal Accounting Officer Ms. Elhan Webb C.F.A.Senior Vice President of Investor RelationsMr. Michael J. Mano J.D. (Age 47)Senior VP, General Counsel & Secretary Compensation: $625.08kMr. James Accumanno J.D.Chief Compliance Officer More Insider Trading Tools from MarketBeat Related Companies BioXcel Therapeutics Insider Buying Verve Therapeutics Insider Buying Aquestive Therapeutics Insider Buying Q32 Bio Insider Buying Alector Insider Buying Akebia Therapeutics Insider Buying Neoleukin Therapeutics Insider Buying Ginkgo Bioworks Insider Buying Canopy Growth Insider Buying Cryoport Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:KPTI) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Karyopharm Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KPTI Stock Alerts